Get Up To $620K for Lab Tech & Public Health Improvements
Posted: April 14, 2016
Summary
Public health laboratories can secure funding to enhance their influenza vaccine virus characterization with advanced molecular detection, or to develop best practices for sharing testing services and improve preparedness through the Vision 2020 program. This funding aims to build critical infrastructure and refine operational standards for more effective public health initiatives.
Eligibility
Full Description
CDC's collaboration with the Association of Public Health Laboratories announces two supplemental funding opportunities. These funding opportunities will be awarded for Advanced Molecular Detection and Vision 2020 - Focus Group Discussions. The purpose of the Advanced Molecular Detection Project is to support state laborartory capacity building to improve characterization of the influenza vaccine viruses by a minimum of two weeks. This project will ensure that the prerequisite infrastructure is available for full production of genomic sequencing prior to the 2016 Influenza season.
The anticipated funding for this activity is $620,000. The Vision 2020 Focus Group Discussions will support the Laborartory Systems and Standards Program to develop best practices and performance quality standards. Develop guidance and tools that assist Public Health Laboratories with developing and supporting regional networks and consortiums for effective sharing of testing and other services that will improve preparedness through established test-sharing mechanisms. The anticipated funding level for this activity is $25,000.